Brind.

The stock of The Joint, a company in the Zacks Medical - HMOs industry, underperformed the S&P 500 on August 8, 2025.

1 report, 1 independent Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The stock of The Joint, a company in the Zacks Medical - HMOs industry, underperformed the S&P 500 on August 8, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • The Joint

    Venue in Paradise, Nevada, United States

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • ZacksThe Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates The Joint Corp. (JYNT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This co